- Home
- CNX vs CORT Comparison
CNX vs CORT Comparison
Compare CNX & CORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CNX | CORT |
|---|---|---|
| Founded | 1860 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Biotechnology: Pharmaceutical Preparations |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.8B | 3.7B |
| IPO Year | 1998 | 2001 |
Fundamental Metrics
Financial Performance| Metric | CNX | CORT |
|---|---|---|
| Price | $39.97 | $38.07 |
| Analyst Decision | Sell | Buy |
| Analyst Count | 8 | 6 |
| Target Price | $34.63 | ★ $107.20 |
| AVG Volume (30 Days) | ★ 1.8M | 1.8M |
| Earning Date | 04-23-2026 | 05-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 763.33 | N/A |
| EPS | ★ 3.98 | 0.82 |
| Revenue | ★ $2,239,134,000.00 | $761,407,000.00 |
| Revenue This Year | $0.27 | $26.08 |
| Revenue Next Year | $9.90 | $31.04 |
| P/E Ratio | ★ $10.19 | $45.78 |
| Revenue Growth | ★ 76.76 | 12.79 |
| 52 Week Low | $27.68 | $28.66 |
| 52 Week High | $43.62 | $114.71 |
Technical Indicators
Market Signals| Indicator | CNX | CORT |
|---|---|---|
| Relative Strength Index (RSI) | 45.27 | 56.34 |
| Support Level | $39.39 | $36.80 |
| Resistance Level | $42.50 | $41.92 |
| Average True Range (ATR) | 1.54 | 2.46 |
| MACD | -0.24 | 0.96 |
| Stochastic Oscillator | 18.25 | 35.18 |
Price Performance
Historical ComparisonAbout CNX CNX Resources Corporation
CNX Resources Corp is an independent natural gas development, production, midstream and technology company centered in the Appalachian Basin. It is focused on unconventional shale formations, prominently the Marcellus Shale and Utica Shale, in Pennsylvania, Ohio and West Virginia. Additionally, the company operates and develops Coalbed Methane (CBM) properties in Virginia. the company has two reportable segments: Shale and Coalbed Methane. The majority of the company's revenue is derived from the Shale segment.
About CORT Corcept Therapeutics Incorporated
Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol. The company's compounds are being evaluated in clinical trials as potential treatments for a variety of serious disorders - hypercortisolism, advanced ovarian cancer, prostate cancer, ALS, and MASH.